Marta Campos Martinez
Head of Investor Relations
Good afternoon, and thanks for becoming a member of us for this particular convention name to debate ROVI’s acquisition of an injectable drug product manufacturing website in Phoenix, Arizona, which we introduced yesterday. Becoming a member of me on the decision immediately is Juan Lopez-Belmonte, ROVI’s Chairman and Chief Govt Officer; and Javier Lopez-Belmonte, ROVI’s Deputy Chairman and Chief Monetary Officer who will focus on the strategic rationale for the acquisition in addition to the important thing phrases of the transaction.
Javier is in Phoenix and he does not have protection. So we hope he can keep linked all through the occasion. You will note an enormous presentation deck within the Traders part of our web site. We’ll work by way of that deck on the decision. And after that, we’ll open it up for Q&A. If you wish to ask any questions throughout the presentation, please do not hesitate to ship them by way of the query backside on the platform.
Earlier than we get began, I observe that some statements we might perhaps contemplate forward-looking statements primarily based on our present beliefs and expectations. Precise outcomes may materially differ on account of recognized and unknown dangers, uncertainties and different components, and we undertake no obligation to replace or revise any of the statements.
So with that, I thanks in your presence right here immediately. And we’ll now hand the presentation over to Juan Lopez-Belmonte, please go forward.
Juan Encina
Chairman & CEO
Thanks, Marta. Good morning, and thanks for becoming a member of us immediately. That is actually an thrilling day for ROVI. I am more than happy to announce our settlement to accumulate
